Commerzbank Aktiengesellschaft United Therapeutics Corp Transaction History

Commerzbank Aktiengesellschaft

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 17, 2020	SELL	$78.31 - $95.34 $3.14 Million - $3.83 Million	-40,129 Closed	0 $0
Q3 2019 Oct 03, 2024	BUY	$74.85 - $85.99 $3 Million - $3.45 Million	40,129 New	40,129 $3.2 Million
Q3 2019 Oct 17, 2019	SELL	$74.85 - $85.99 $16,916 - $19,433	-226 Reduced 0.56%	40,129 $3.2 Million
Q2 2019 Oct 03, 2024	BUY	$76.06 - $120.81 $3.07 Million - $4.88 Million	40,355 New	40,355 $3.15 Million
Q2 2019 Jul 23, 2019	BUY	$76.06 - $120.81 $43,354 - $68,861	570 Added 1.43%	40,355 $3.15 Million
Q1 2019 Oct 03, 2024	BUY	$107.15 - $126.84 $4.26 Million - $5.05 Million	39,785 New	39,785 $4.67 Million
Q4 2018 Oct 03, 2024	BUY	$101.4 - $128.73 $4.03 Million - $5.12 Million	39,785 New	39,785 $4.33 Million
Q3 2018 Oct 04, 2024	BUY	$113.81 - $129.46 $4.53 Million - $5.15 Million	39,785 New	39,785 $5.09 Million
Q2 2018 Oct 04, 2024	BUY	$101.14 - $118.31 $4.02 Million - $4.71 Million	39,785 New	39,785 $4.5 Million
Q4 2017 Oct 04, 2024	BUY	$118.58 - $151.28 $4.72 Million - $6.02 Million	39,785 New	39,785 $5.89 Million
Q2 2017 Aug 09, 2017	BUY	N/A	39,785	39,785 $5.16 Million

679

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.